| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |